<p>(A) Unsupervised clustering of proteomic profile of patient tumors and BCXs as determined by RPPA. Each protein tested represents a column: Red, high expression; green, low expression. Samples are listed on the right side. Left, cluster trees of sample groups; top, cluster trees of proteins. Each BCX model’s P1-3 generation clustered together, demonstrating relative stability of the proteomic profile once growth in mouse is established. However, all P0 generations clustered together, suggesting that differences between patient tumor-xenograft proteomic profiles is greater than inter-tumoral differences. (B) Selected proteins and phosphoproteins that are differentially expressed between patient tumors (P0) and the first-generation of BCXs...
Background: The majority of genetic biomarkers for human cancers are defined by statistical screenin...
Phosphate and tensin homolog on chromosome ten (PTEN) germline mutations are associated with an over...
Cancer susceptibility has been attributed to at least one heterozygous genetic alteration in a tumor...
International audienceABSTRACT: INTRODUCTION: Identification of new therapeutic agents for breast ca...
derived from them. Cluster was based on the 914 genes reporting at least 4-fold difference in expres...
<p>(<b>A</b>) The cumulative distribution of the somatic mutations identified on the targeted exons ...
<p>(A) A PCA plot based on the peptide profile in control and SB-431542-treated tumors using SMCA13 ...
Phosphate and tensin homolog on chromosome ten (PTEN) germline mutations are associated with an over...
Background: Genomic gains and losses are a result of genomic instability in many types of cancers. B...
Background Advancements in sequencing technologies have led to useful molecular classifications of b...
Patient-derived xenograft (PDX) tumor model is a powerful technology in evaluating anti-cancer drugs...
<p>(A) Clustering of whole exome sequencing mutation data based on the mutation status of the genes ...
Background: Recent advances have been made in targeting the phosphoinositide 3-kinase pathway in bre...
The Cancer Genome Atlas (TCGA) project has generated abundant genomic data for human cancers of vari...
<p>(A) Recall (grey) and precision (tan) of detected somatic mutations. Recall = number of somatic m...
Background: The majority of genetic biomarkers for human cancers are defined by statistical screenin...
Phosphate and tensin homolog on chromosome ten (PTEN) germline mutations are associated with an over...
Cancer susceptibility has been attributed to at least one heterozygous genetic alteration in a tumor...
International audienceABSTRACT: INTRODUCTION: Identification of new therapeutic agents for breast ca...
derived from them. Cluster was based on the 914 genes reporting at least 4-fold difference in expres...
<p>(<b>A</b>) The cumulative distribution of the somatic mutations identified on the targeted exons ...
<p>(A) A PCA plot based on the peptide profile in control and SB-431542-treated tumors using SMCA13 ...
Phosphate and tensin homolog on chromosome ten (PTEN) germline mutations are associated with an over...
Background: Genomic gains and losses are a result of genomic instability in many types of cancers. B...
Background Advancements in sequencing technologies have led to useful molecular classifications of b...
Patient-derived xenograft (PDX) tumor model is a powerful technology in evaluating anti-cancer drugs...
<p>(A) Clustering of whole exome sequencing mutation data based on the mutation status of the genes ...
Background: Recent advances have been made in targeting the phosphoinositide 3-kinase pathway in bre...
The Cancer Genome Atlas (TCGA) project has generated abundant genomic data for human cancers of vari...
<p>(A) Recall (grey) and precision (tan) of detected somatic mutations. Recall = number of somatic m...
Background: The majority of genetic biomarkers for human cancers are defined by statistical screenin...
Phosphate and tensin homolog on chromosome ten (PTEN) germline mutations are associated with an over...
Cancer susceptibility has been attributed to at least one heterozygous genetic alteration in a tumor...